Why Cigna Deal With Humana Made Little Sense To Begin With
Cigna Group confirmed it is "not pursuing a combination with Humana, a big provider of Medicare Advantage coveage.
Harrow Announces Market Access Wins for VEVYE®
Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced its first major market access ...
GoodRx accused of conspiring with PBMs over reimbursement fees
Community Care's legal action only names GoodRx as a defendant. The two other cases name them as well as PBMs CVS Caremark ...
Rebate Game Played By PBMs And Drug Makers Limits Biosimilar Competition
The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.
CVS, Ex-Cigna Executive Ask to Shorten Ban on Starting New Role
CVS Pharmacy Inc. and the former president of Cigna Corp.'s Express Scripts asked a federal judge to amend an injunction ...
ophthalmologytimes1d
Harrow announces expanded market access for cyclosporine ophthalmic solution in 2025 Medicare Part D Program
According to the company, effective January 1, 2025, cyclosporine ophthalmic solution 0.1% (Vevye) will be included on key ...
Hometown Pharmacy closing 5 Wisconsin stores after shuttering 6 since last year
The Rio-based network of independent pharmacies blames drug industry intermediaries known as pharmacy benefit managers.
Insurancenewsnet.com6d
Pharmacy Benefit Manager math: Big chains paid $23.55 to fill a blood pressure Rx. Small drugstores paid $1.51
Pharmacy Benefit Managers are the middlemen who manage virtually all prescriptions written in the U.S. Serving as brokers among drugmakers, pharmacies, and health insurers, these health care entities ...
Cencora Ends 2024 With Double-Digit Growth From GLP-1s and Favorable Drug Trends
Cencora simplifies distribution logistics by shipping products to centralized wholesaler locations, as opposed to shipping directly to pharmacies and various customer locations. Additionally, Cencora ...